Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
RENEWED: A follow-up study of the opicinumab phase 2 RENEW study in participants with acute optic neuritis.
Aktas O, Ziemssen F, Ziemssen T, Klistorner A, Butzkueven H, Izquierdo G, Leocani L, Balcer LJ, Galetta SL, Castrillo-Viguera C, Bradley DP, Naylor ML, Belachew S, Franchimont N, Zhu B, Cheng W; RENEWED Investigators. Aktas O, et al. Among authors: ziemssen f. Mult Scler Relat Disord. 2024 Nov 24;93:106185. doi: 10.1016/j.msard.2024.106185. Online ahead of print. Mult Scler Relat Disord. 2024. PMID: 39662163 Free article.
Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential.
Klistorner A, Chai Y, Leocani L, Albrecht P, Aktas O, Butzkueven H, Ziemssen T, Ziemssen F, Frederiksen J, Xu L, Cadavid D; RENEW MF-VEP Investigators. Klistorner A, et al. Among authors: ziemssen t, ziemssen f. CNS Drugs. 2018 Dec;32(12):1159-1171. doi: 10.1007/s40263-018-0575-8. CNS Drugs. 2018. PMID: 30267385 Free PMC article.
Outcomes of treatment of pediatric choroidal neovascularization with intravitreal antiangiogenic agents: the results of the KKESH International Collaborative Retina Study Group.
Kozak I, Mansour A, Diaz RI, Calzada JI, Pichi F, Cruz-Villegas V, Diaz-Llopis M, Gallego-Pinazo R, Chhablani J, Martinez-Cartier M, Meerhoff M, Mieler WF, Arevalo JF; King Khaled Eye Specialist Hospital International Collaborative Retina Study Group. Kozak I, et al. Retina. 2014 Oct;34(10):2044-52. doi: 10.1097/IAE.0000000000000200. Retina. 2014. PMID: 24978669
Brolucizumab and Platelet Activation and Reactivity.
Sobolewska B, Poeschel S, Kalbacher H, Bieber K, Paczulla Stanger AM, Stellos K, Ziemssen F. Sobolewska B, et al. Among authors: ziemssen f. Curr Eye Res. 2025 Jan 6:1-10. doi: 10.1080/02713683.2024.2441245. Online ahead of print. Curr Eye Res. 2025. PMID: 39760267
Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration.
Loewenstein A, Sylvanowicz M, Amoaku WM, Aslam T, Cheung CMG, Eldem B, Finger RP, Gale RP, Kodjikian L, Koh A, Korobelnik JF, Lin X, Mitchell P, Murphy M, Okada M, Pearce I, Rodriguez FJ, Stern J, Talks SJ, Wong DT, Wong TY, Ziemssen F, Barratt J. Loewenstein A, et al. Among authors: ziemssen f. Ophthalmol Ther. 2024 Dec 14. doi: 10.1007/s40123-024-01061-3. Online ahead of print. Ophthalmol Ther. 2024. PMID: 39673040
Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic Staff.
Ziemssen F, Sylvanowicz M, Amoaku WM, Aslam T, Eldem B, Finger RP, Gale RP, Kodjikian L, Korobelnik JF, Lin X, Loewenstein A, Mitchell P, Murphy M, Owens DR, Parker N, Pearce I, Rodríguez FJ, Stern J, Talks SJ, Wong DT, Wong TY, Barratt J. Ziemssen F, et al. Ophthalmol Ther. 2024 Dec 14. doi: 10.1007/s40123-024-01060-4. Online ahead of print. Ophthalmol Ther. 2024. PMID: 39673039
[EyeMatics-Multicenter data evaluation of real-world data with interoperable medical informatics].
Holtrup L, Varghese J, Schuster AK, Poschkamp B, Hampf C, Waltemath D, Wahle L, Lipprandt M, Merle DA, Berens P, Kohlbacher O, Kakkassery V, Bartos M, Ziemssen F, Wendt T, Hoffmann K; EyeMatics Study Group; Eter N. Holtrup L, et al. Among authors: ziemssen f. Ophthalmologie. 2024 Nov 14. doi: 10.1007/s00347-024-02135-0. Online ahead of print. Ophthalmologie. 2024. PMID: 39542916 Review. German.
Letter to the Editor: LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the LumiTheraTM Valeda Light Delivery System.
Feltgen N, Ach T, Bartz-Schmidt U, Bechrakis N, Eter N, Hattenbach L, Heimann H, Hoerauf H, Lommatzsch A, Priglinger S, Stahl A, Walter P, Wolf A, Ziemssen F, Grisanti S. Feltgen N, et al. Among authors: ziemssen f. Retina. 2024 Sep 19. doi: 10.1097/IAE.0000000000004265. Online ahead of print. Retina. 2024. PMID: 39316834 No abstract available.
238 results